Bio Medica Laboratories IPO
LISTEDSMEListing Performance
▼ 20.00%
Issue Price
₹139
Listing Price
₹111
Listed On
29 May 2026
- Price Band
- ₹132 – ₹139
- Lot Size
- 1,000
- Lot Value
- ₹1,39,000
- Open Date
- 21 May21 May 2026
- Close Date
- 25 May25 May 2026
- Min Investment
- ₹1,39,000
Demand snapshot
Subscription and grey market data as reported. Not a recommendation.
- Subscribed 2.31x (QIB 15.94x, NII 1.41x, Retail 2.92x) at close
Application Lot Sizes
Retail caps at ₹2,00,000 (1 lots here). S-HNI is ₹2L–₹10L, B-HNI is above ₹10L.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 1,000 | ₹1,39,000 |
| Retail (max) | 1 | 1,000 | ₹1,39,000 |
| S-HNI (min) | 2 | 2,000 | ₹2,78,000 |
| S-HNI (max) | 7 | 7,000 | ₹9,73,000 |
| B-HNI (min) | 8 | 8,000 | ₹11,12,000 |
Subscription Status
| Category | Day 5 |
|---|---|
| QIB | 15.94x |
| sNII (S-HNI) | — |
| bNII (B-HNI) | — |
| Retail | 2.92x |
| Total | 2.31x |
Colour: red <1x · amber 1–10x · green ≥10x oversubscribed.
Allotment Statistics
Retail Individual Investors (RII)
Subscription
2.92x
Allotment Ratio
1 lot per 3 applicants
Allotment Probability
~34.2%
Non-Institutional Investors (NII / HNI)
Subscription
1.41x
Allotment Type
Proportionate allotment
Qualified Institutional Buyers (QIB)
Subscription
15.94x
Allotment Type
Discretionary allotment
Total Subscription
2.31x
Allotment probability is estimated based on subscription data and is not guaranteed. Actual allotment depends on the registrar's process.
Basis of Allotment
Category-wise subscription & allotment ratio
Weigh your chances
IPO Timeline
Issue Opens
21 May 2026 · Thu
Issue Closes
25 May 2026 · Mon
Bidding Cut-off (UPI Mandate)
25 May 2026 · 5:00 PM IST
Allotment
26 May 2026 · Tue
Listing
29 May 2026 · Fri
Issue Opens
21 May 2026 · Thu
Issue Closes
25 May 2026 · Mon
Bidding Cut-off (UPI Mandate)
25 May 2026 · 5:00 PM IST
Allotment
26 May 2026 · Tue
Listing
29 May 2026 · Fri
IPO Details
| Registrar | Skyline Financial Services Pvt.Ltd. |
| Exchange | NSE SME |
| ISIN | — |
| Face Value | ₹10 |
| Issue Size | ₹52.00 Cr |
| Fresh Issue | — |
| OFS Size | — |
| Lead Managers | — |
3-Year Financial Summary
Financial data not available yet.
Check the valuation yourself
Company Fundamentals
Capital Structure
Capital structure not yet available.
Shareholding Pattern
Shareholding pattern not yet available.
Reservations & OFS
Reservation & OFS detail not yet available.
Board & Management
Board & management not yet available.
Industry & Market
Industry & market data not yet available.
Registrar (RTA)
SEBI-registered Registrar & Transfer Agent — handles allotment and refunds.
Registrar:Skyline Financial Services Pvt.Ltd.→Documents
Frequently Asked Questions
When is the Bio Medica Laboratories IPO opening?
The Bio Medica Laboratories IPO opens on 21 May 2026 and closes on 25 May 2026. Check this page for the latest updates as we refresh every 30 minutes.
What is the price band of the Bio Medica Laboratories IPO?
The price band for the Bio Medica Laboratories IPO is ₹132 to ₹139. The final price is announced after the book-building process and is confirmed before listing.
What is the lot size and minimum investment for the Bio Medica Laboratories IPO?
The minimum lot size is 1000 shares with a minimum investment of ₹1,39,000. Retail investors can apply for up to the retail limit defined by SEBI.
What is the GMP of Bio Medica Laboratories IPO today?
The latest Grey Market Premium for Bio Medica Laboratories is ₹2 (+1.00%). GMP is unofficial data and is not a guarantee of listing price.
When will the Bio Medica Laboratories IPO list on NSE and BSE?
The Bio Medica Laboratories IPO is expected to list on 29 May 2026 on NSE SME. Actual listing day trading begins at the start of the normal market session.
How can I check the Bio Medica Laboratories IPO allotment status?
The registrar for this IPO is Skyline Financial Services Pvt.Ltd.. You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.
Is the Bio Medica Laboratories IPO a mainboard or SME issue?
Bio Medica Laboratories is a SME IPO that will list on the NSE Emerge or BSE SME platform. SME IPOs require a minimum application value of one lakh rupees.
How do I apply for the Bio Medica Laboratories IPO?
You can apply for the Bio Medica Laboratories IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA while the issue is open for bidding.
What is the GMP-implied price of Bio Medica Laboratories IPO?
The GMP-implied price (unofficial, not a forecast) is ₹141: the upper price band of ₹139 plus the latest grey market premium of ₹2, as of 25 May 2026, 10:00 AM IST. GMP is unofficial grey market data, and the actual listing price can differ from it.
What is the allotment ratio for Bio Medica Laboratories IPO?
Based on the retail subscription of 2.92x, the estimated allotment ratio is 1 lot per 3 applicants (approximately 34.2% chance of allotment). This is an estimate and actual allotment may vary.
Recently Listed IPOs
| Company | Listed | Listing Gain |
|---|---|---|
| Peshwa Wheat | 01 Oct 2026 | -0.94% |
| Roopa Screen | 01 Oct 2026 | +90.00% |
| Coreintegra Consulting Services | 30 Sep 2026 | +0.13% |
Related IPOs
Related Articles
How to Use 10 Minutes of Research to Validate Any IPO Video You Watch
SEBI now requires issuers to publish a 10-minute IPO disclosure video. Here is a practical, source-by-source method to verify what you watch against the DRHP and official exchange records in about ten minutes.
Read more →
How-ToHow to Read Past IPO Data to Set Realistic Listing Gain Targets
Median listing gains fell to 3.8% in 2025 from 15.2% in 2024. Here is how to read past IPO data, GMP, and subscription numbers to set realistic listing day expectations instead of chasing hype.
Read more →
How-ToHow to Compare an IPO With Listed Peers Using Key Ratios and Growth Metrics
A practical framework for Indian retail investors on comparing an IPO with its listed peers using P/E, P/B, EV/EBITDA and growth metrics, illustrated with the NSE vs BSE case study.
Read more →